Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

This is the first study in people testing a new drug called TQB2934 for multiple myeloma, a type of blood cancer. The main goal is to check if the injection is safe and to see how the body processes it. The drug works by connecting a patient's own immune cells to the cancer cells…